Search PubMed⌕ Search

Biomedical subjects

J P Raynaud

Publications and source records attributed to J P Raynaud.

At least 91 records · Page 5Linked to original sources
PubMed1982

New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogen.

In order to block the influence of androgens from all sources on the growth of prostatic cancer, we have used a new hormonal therapy based on medical castration achieved with the potent LHRH agonist [D-Ser(TBU)6, des-Gly-NH2(10)]LHRH ethylamide (HOE-766) combined with the administration of a pure antiandrogen that neutralizes the action of adrenal androgens as well as those still secreted in low amounts by the testis during LHRH agonist treatment. This study was performed in ten patients with advanced prostatic carcinoma (9 at stage D2 and one at stage C). Bone pain, prostatism and general well-being were 60 to 90% improved within one month after starting treatment in all patients. After 2 months of treatment, minimal bone pain remained only in one patient who was originally bedridden. Bone scanning showed a 70 to 90% decrease in uptake after 3 to 5 months of treatment in the patients studied. Acid phosphatase levels were 60 to 90% reduced after 2 months of treatment in 3 out of the 4 patients who had elevated levels before therapy. Marked objective and subjective improvement was thus rapidly observed in 9 out of 10 patients treated with the combined therapy, while, in the other patient at stage C, subjective improvement could be documented. Although preliminary, this study indicates that a combined hormonal therapy which neutralizes all androgenic influences on peripheral tissues is of potential benefit in prostatic cancer. Moreover, the ease of application as well as the lack of secondary effects of the present approach should make possible its use early in the disease and should thus minimize the development of metastases and androgen-resistant cell clones. Randomized prospective studies on this potentially beneficial therapy are warranted.

Adenocarcinoma↗
PubMed1981

[Ultrastructural localization of estradiol and moxestrol in the gonadotropic cells of rat by immunocytology after cryo-ultramicrotomy: evidence for hormonal specificity (author's transl)].

Estradiol (E2) was specifically localized by immunocytochemistry in the cytoplasm and in the nucleus of the gonadotropic cells. The immunocytochemical reaction was not observed after injection of moxestrol, but it was not modified by injection of testosterone, progesterone, or dexamethasone. These data suggest that E2 might be bound to a high-affinity binding-site which could also have a hormonal specificity.

Animals↗
PubMed1981

Additive inhibitory effects of treatment with an LHRH agonist and an antiandrogen on androgen-dependent tissues in the rat.

Combined treatment of adult male rats with the LHRH agonist, [D-Ser(TBU)6, des-Gly-NH2(10)]LHRH ethylamide, and a non-steroid antiandrogen, RU 23908, led to a rapid and marked atrophy of the ventral prostate and seminal vesicles. Treatment with the LHRH agonist decreased androgen secretion and thus facilitated the action of the antiandrogen in androgen-dependent tissues. Such a combined treatment could be useful in the treatment of androgen-dependent pathologies in man, particularly in prostatic adenocarcinoma and possibly benign prostatic hyperplasia.

Animals↗
PubMed1981

Major internal parasites interfering with cattle production in France, and experiments to control them by strategic treatments. A bibliographic review.

A summary of the cattle management systems and statistics in France is presented as a framework to examine the recently published results on the major internal parasites of cattle in France from numeric data on naturally infested animals. From these results the major or constant parasites are Fasciola, Dictyocaulus, Ostertagia and Cooperia; occasional but important parasites are Nematodirus, Neoascaris, Eimeria, OEsophagostomum and Cysticercus bovis. Pathology results focus on disease given by the most common nematode : Ostertagiasis. For prevention and control of infestations in farm practice with typical management procedures, results are presented in dairy cattle (Brittany and Normandy), and in beef cattle (Limousin).

Animals↗
PubMed1981

A swine dysentery model for evaluation of drug prophylaxis: development of a model involving oral infection plus pen contamination.

To overcome some of the inadequacies of the classic artificial swine dysentery (SD) model that is frequently used to judge the efficacy of drugs in preventing SD, a model has been developed that produces SD comparable with natural infections that are frequently encountered in commercial pig production facilities. The model is a combination of a single oral infection (OI) plus pen contamination (PC), conducted each night for 25 nights. Results with OI alone, PC alone, and OI + PC have been compared, and the new model (OI + PC) produced consistent, homogeneous, and severe SD with 100% morbidity and 92% mortality.

Administration, Oral↗
PubMed1981

A swine dysentery model for evaluation of drug prophylaxis: efficacy of various drugs in the control of swine dysentery.

A swine dysentery (SD) model that produces consistent, homogeneous, and severe SD was used in 2 experiments to compare the prophylactic effectiveness of 5 commercially available swine feed additive products. Under the conditions of these studies, carbadox and carbadox + sulfamethazine proved to be the most effective agents in preventing SD during the infection + medication and postmedication periods. Olaquindox was effective in preventing SD in the infection + medication period; however, SD recurrence was high during the postmedication period. Nithiamide and chlortetracycline + sulfamethazine + penicillin were least effective in preventing SD during the infection + medication and postmedication periods.

Animals↗
PubMed1980

Detection and localization of 14-3-2 protein in primary cultures of embryonic rat brain.

The development of embryonic rat brain in cell cultures was studied by an immunocytochemical method based on the detection of 14-3-2 protein (neuron-specific enolase or NSE), a neuron-specific protein. This protein was already present in undifferentiated neurons (less than 5 days in culture), being dispersed throughout the cytoplasm, though seemingly concentrated in the vicinity of polyribosomal structures. It was not found in nuclei, in mitochondria or in the Golgi apparatus. During neuron differentiation, the location of 14-3-2 protein was related to neurite development insofar as it was detected along the axon and even in what could be taken to be the presynaptic region of numerous interneuron contacts. In contact areas, a thickening of the junction membrane was observed but the presence of 14-3-2 protein was always unilateral demonstrating the absence of a true synapse and reflecting the halt in neurite development observed after 15 days in culture. The presence of 14-3-2 protein in the cell cultures was confirmed by a microcomplement fixation assay. The protein detected in cell cultures had the same immunological properties as that found in the 17-day-old embryo, but was slightly different from that found in adult rat brain. This observation can be confronted with the lack of neuron maturation in the immunocytochemical studies.

Animals↗